Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Manufacturers Look to Vaccines for Growth and Innovation

Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.
Feb 2, 2010

Vaccine R&D is surging, but continues to raise manufacturing and regulatory challenges.

Pharma Faces Multiple Challenges in the Year Ahead

Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.
Jan 2, 2010

Globalization and reform initiatves will shape pharma production, pricing, and pipelines in 2010.

Generic Drugs Come of Age

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.
Dec 2, 2009

Generic-drug manufacturers look to expand into biologics and complex dosage forms. This article contains bonus online-exclusive material.

Safety versus Speed in Drug Development

The heightened focus on risk raises concerns about delays in approving new drugs.
Nov 2, 2009

The heightened focus on risk raises concerns about delays in approving new drugs.

New Leadership Seeks to Transform FDA

Strict enforcement, new rules, and organizational changes signal an activist tone.
Oct 2, 2009

Strict enforcement, new rules, and organizational changes signal an activist tone.

Global Health Concerns Create Business Opportunities

Health crises generate support for new vaccines and treatments for diseases found in developing nations.
Sep 2, 2009

Health crises generate support for new vaccines and treatments for diseases found in developing nations.

Pharma Girds for Healthcare Reform

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.
Aug 2, 2009

Pressure to reduce healthcare spending has put drug rebates, price cuts, and tax hikes on the table.

Manufacturers Face New Risk-Management Requirements

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.
Jul 2, 2009

REMS to improve the safe use of opioids may lead to controls on other high-risk medicines.

FDA Commissioner Hamburg Discusses Drug Regulation

Jun 22, 2009

The new commissioner of the US Food and Drug Administration is mapping plans for turning around an agency that has been demoralized, buffeted about in the press and has lost some of the trust of the American people.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
FindPharma Custom Search
Click here